Targeting lentiviral vector to specific cell types through surface displayed single chain antibody and fusogenic molecule

Virology Journal

Volumn 7, Issue , 2010, Pages

  Lei, Yuning ^a   Joo, Kye Il ^a   Zarzar, Jonathan ^a   Wong, Clement ^a   Wang, Pin ^a  

^a University of Southern California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD20 ANTIBODY; CD20 ANTIGEN; FUSOGENIC PROTEIN; HLA A2 ANTIGEN; IMMUNOGLOBULIN G; LENTIVIRUS VECTOR; SINGLE CHAIN ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS FUSION PROTEIN;

ANTIGEN BINDING; ARTICLE; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HEAVY CHAIN; HINGE REGION; HUMAN; HUMAN CELL; LIGHT CHAIN; PROTEIN DOMAIN; VIRAL GENE DELIVERY SYSTEM; CELL LINE; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METABOLISM; METHODOLOGY; PHYSIOLOGY; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS ENTRY;

CELL LINE; GENE THERAPY; GENETIC VECTORS; HUMANS; LENTIVIRUS; SINGLE-CHAIN ANTIBODIES; TRANSDUCTION, GENETIC; VIRAL FUSION PROTEINS; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 77749316981     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-35     Document Type: Article

References (38)

1. Gene therapy - promises, problems and prospects. I Verma N Somia., Nature 1997 389 239 242 10.1038/38410 9305836
2. Gene therapy: twenty-first century medicine. I Verma M Weitzman, Annu Rev Biochem 2005 74 711 738 10.1146/annurev.biochem.74.050304.091637 15952901
3. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. J Burns T Friedmann W Driever M Burrascano J Yee, Proc Nat Acad Sci USA 1993 90 8033 8037 10.1073/pnas.90.17.8033 8396259
4. Altering the tropism of lentiviral vectors through pseudotyping. J Cronin X Zhang J Reiser, Curr Gene Ther 2005 5 387 398 10.2174/1566523054546224 16101513
5. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH. P Mastromarino C Conti P Goldoni B Hauttecoeur N Orsi, J Gen Virol 1987 68 2359 2369 10.1099/0022-1317-68-9-2359 2821175
6. Interactions of a vesicular stomatitis virus G protein fragment with phosphatidylserine: NMR and fluorescence studies. M Hall K Burson W Huestis, Biochim Biophys Acta 1998 1415 101 113 10.1016/S0005-2736(98)00186-2 9858700
7. Amphotropic retroviral vectors displaying hepatocyte growth factor-envelope fusion proteins improve transduction eficiency of primary hepatocytes. T Nguyen JC Pages D Farge P Briand A Weber, Hum Gene Ther 1998 17 2469 2474 10.1089/hum.1998.9.17-2469
8. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. N Somia M Zoppe I Verma, Proc Nat Acad Sci USA 1995 92 7570 7574 10.1073/pnas.92.16.7570 7638232
9. In vivo cell type-specific gene delivery with retroviral vectors that display single chain antibodies. A Jiang R Dornburg, Gene Ther 1999 6 1982 1987 10.1038/sj.gt.3301043 10637449
10. Envelope-targeted retrovirus vectors transduce melanoma xenografts but not sleen or liver. F Martin S Chowdhury S Neil N Phillipps MK Collins, Mol Ther 2002 5 269 274 10.1006/mthe.2002.0550 11863416
11. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. S Valsesia-Wittmann A Drynda G Deleage M Aumailley J Heard O Danos G Verdier F Cosset, J Virol 1994 68 4609 4619 8207835
12. Tissu-specific targeting of retroviral vectors through ligand-receptor interactions. N Kasahara A Dozy Y Kan, Science 1994 266 1373 1376 10.1126/science.7973726 7973726
13. Cell type-specific gene transfer into human cells with retroviral vectors that display single chain antibodies. A Jiang T Chu F Nocken K Cichutek R Dornburg., J Virol 1998 72 10148 10156 9811755
14. Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide. M Maurice E Verhoeyen P Salmon D Trono SJ Russell FL Cosset, Blood 2002 99 2342 2350 10.1182/blood.V99.7.2342 11895766
15. A Hyperfusogenic Gibbon Ape Leukemia Envelope Glycoprotein: Targeting of a Cytotoxic Gene by Ligand Display. AK Fielding SC Fernandes MP Chadwick FJ Bullough FL Cosset, Hum Gene Ther 2000 11 817 826 10.1089/10430340050015437 10779159
16. Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. TJ Gollan MR Green, J Virol 2002 76 3564 3569 10.1128/JVI.76.7.3564-3569.2002 11884581
17. Antibody-directed targeting of retroviral vectors via cell surface antigens. K Morizono G Bristol Y Xie S Kung I Chen, J Virol 2001 75 8016 8020 10.1128/JVI.75.17.8016-8020.2001 11483746
18. Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. K Morizono Y Xie G Ringpis M Johnson H Nassanian B Lee L Wu ISY Chen, Nat Med 2005 11 346 352 10.1038/nm1192 15711560
19. A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse esctropic murine leukemia virus-derived viruses. P Roux P Jeanteur M Piechaczyk, Proc Nat Acad Sci USA 1989 86 9079 9083 10.1073/pnas.86.23.9079 2556698
20. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. A Boerger S Snitkovsky J Young, Proc Nat Acad Sci USA 1999 96 9867 9872 10.1073/pnas.96.17.9867 10449786
21. Targeting lentiviral vectors to specific cell types in vivo. L Yang L Bailey D Baltimore P Wang, Proc Nat Acad Sci USA 2006 103 11479 11484 10.1073/pnas.0604993103 16864770
22. The Chloesterol Requirement for Sindbis Virus Entry and Exit and Characterization of a Spike Protein Region Involved in Cholesterol Dependence. L Lu T Cassese M Kielian, J Virol 1999 73 4272 4278 10196324
23. Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors. Y Lei KI Joo P Wang, J Biol Eng 2009 3 8 10.1186/1754-1611-3-8 19490632
24. Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. H Yang L Zeigler K-I Joo T Cho Y Lei P Wang, Biotechnol Bioeng 2008 101 357 368 10.1002/bit.21903 18435481
25. Design of transgenes for efficient expression of active chimeric proteins on mammalian cells. K Liao W Chou Y Lo S Roffler, Biotechnol Bioeng 2000 73 313 323 10.1002/bit.1064
26. Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells. W Chou K Liao Y Lo S Jiang M Yeh S Roffler, Biotechnol Bioeng 1999 65 160 169 10.1002/(SICI)1097-0290(19991020)65:2<160::AID- BIT5>3.0.CO;2-U 10458736
27. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity. K Liao B Chen T Liu S Tzou Y Lin K Lin C Su S Roffler, Cancer Gene Ther 2003 10 10 779 90 10.1038/sj.cgt.7700637 14502231
28. A membrane antibody receptor for noninvasive imaging of gene expression. S Roffler H Wang H Yu W Chang C Cheng Y Lu B Chen T Cheng, Gene Ther 2006 13 412 420 10.1038/sj.gt.3302671 16267569
29. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus. B Fredericksen B Wei J Yao T Luo J Garcia, J Virol 2002 76 11440 11446 10.1128/JVI.76.22.11440-11446.2002 12388705
30. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism. M McClure M Marsh R Weiss, EMBO J 1988 7 513 518 3259178
31. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus. DL Gibbons MC Vaney A Roussel A Vigouroux B Reilly J Lepault M Kielan FA Rey, Nature 2004 427 320 325 10.1038/nature02239 14737160 (Pubitemid 38133653)
32. virus memrane-fusion proteins: more than one way to make a hairpin. M Kielian FA Rey, Nat Rev Microbiol 2006 4 67 76 10.1038/nrmicro1326 16357862
33. E1 mutants identify a critical region in the trimer interface of the semliki forest virus fusion protein. CY Liu M Kielian, J Virol 2009 83 21 11298 11306
34. HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with virions. K Leung JO Kim L Ganesh J Kabat O Schwartz GJ Nabel, Cell Host Microbe 2008 3 285 292 10.1016/j.chom.2008.04.004 18474355
35. Foreign glycoproteins can be actively recruited to virus assembly sites during pseudotyping. RL Jorgenson VM Vogt MC Johnson, J Virol 2009 83 4060 4067 10.1128/JVI.02425-08 19224995
36. A stable system for the high-titer production of multiply attenuated lentiviral vectors. N Klages R Zufferey D Trono, Mol Ther 2000 2 170 176 10.1006/mthe.2000.0103 10947945
37. Low-pH-dependent fusion of sindvis virus with receptor-free cholesterol- and sphingolipid-containing liposomes. JM Smit R Bittman J Wilschut, J Virol 1999 73 8476 8484 10482600
38. Kinetics of fusion and lipid transfer between virus receptor containing liposomes and influenza viruses as measured with the octadecylrhodamine B chloride assay. H Wunderli-Allenspach S Ott, Biochemistry 1990 29 1990 1997 10.1021/bi00460a005 2328232